Expertise in
8
conditions

Dr. Martina Crysandt

Hematology | Oncology
Rachel Loschiavo PA-C
825 Eastlake Ave E, 
Seattle, WA 
Expertise in
8
conditions
Rachel Loschiavo PA-C
825 Eastlake Ave E, 
Seattle, WA 

Overview

Martina Crysandt is a Hematologist and an Oncologist practicing medicine in Seattle, Washington.

Dr. Crysandt is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelofibrosis, Febrile Neutropenia, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 63 peer reviewed articles and participating in 3 clinical trials.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in WA

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Rachel Loschiavo Pa-C
825 Eastlake Ave E, Seattle, WA 98109

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
A Randomized, Open-label, Phase 2 Trial of Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia to Characterize the Efficacy and Safety of a Range of Doses
Enrollment Status: Completed
Publish Date: March 17, 2026
Intervention Type: Drug
Study Drug: Ponatinib
Study Phase: Phase 2
Ruxolitinib Versus Allogeneic Stem Cell Transplantation for Patients With Myelofibrosis According to Donor Availability: A Prospective Phase II Trial (MMM 02 Study)
Ruxolitinib Versus Allogeneic Stem Cell Transplantation for Patients With Myelofibrosis According to Donor Availability: A Prospective Phase II Trial (MMM 02 Study)
Enrollment Status: Active_not_recruiting
Publish Date: March 30, 2025
Intervention Type: Drug, Procedure
Study Drug: Ruxolitinib continuous therapy
Study Phase: Phase 2
10-day Decitabine Versus Conventional Chemotherapy (3+7) Followed by Allografting in AML Patients ≥ 60 Years: a Randomized Phase III Study of the EORTC Leukemia Group, CELG, GIMEMA and German MDS Study Group
10-day Decitabine Versus Conventional Chemotherapy (3+7) Followed by Allografting in AML Patients ≥ 60 Years: a Randomized Phase III Study of the EORTC Leukemia Group, CELG, GIMEMA and German MDS Study Group
Enrollment Status: Unknown
Publish Date: February 15, 2023
Intervention Type: Drug
Study Drugs: Decitabine, Daunorubicin, Cytarabine, Idarubicin, Etoposide
Study Phase: Phase 3
View 2 Less Clinical Trials

63 Total Publications

Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX).
Journal: Leukemia
Published: October 28, 2025
Similar Doctors
Expertise in
15
conditions
Dr. Douglas Hawkins
Hematology | Oncology
Expertise in
15
conditions
Dr. Douglas Hawkins
Hematology | Oncology
Referral may be required

Seattle Children's Hospital

4800 Sand Point Way NE, 
Seattle, WA 
 (3.3 miles away)
206-987-2000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Douglas Hawkins is a Hematologist and an Oncologist practicing medicine in Seattle, Washington. Dr. Hawkins is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Rhabdomyosarcoma, Adult Soft Tissue Sarcoma, Osteosarcoma, Osteotomy, and Bone Marrow Aspiration.

Expertise in
17
conditions
Dr. Hans-peter Kiem
Hematology | Oncology
Expertise in
17
conditions
Dr. Hans-peter Kiem
Hematology | Oncology
Referral may be required

Gme Office University Of Washington

1959 NE Pacific St, 
Seattle, WA 
 (1.9 miles away)
206-543-3360
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Hans-peter Kiem is a Hematologist and an Oncologist practicing medicine in Seattle, Washington. Dr. Kiem is highly rated in 17 conditions, according to our data. His clinical expertise encompasses X-Linked Severe Combined Immunodeficiency, Severe Combined Immunodeficiency (SCID), Congenital Aplastic Anemia, Fanconi Anemia, and Bone Marrow Transplant.

Expertise in
7
conditions
Dr. Mignon Loh
Hematology | Oncology
Expertise in
7
conditions
Dr. Mignon Loh
Hematology | Oncology
Referral may be required

Seattle Children's Hospital

4800 Sand Point Way NE, 
Seattle, WA 
 (3.3 miles away)
206-987-2106
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mignon Loh is a Hematologist and an Oncologist practicing medicine in Seattle, Washington. Dr. Loh is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Acute Lymphoblastic Leukemia (ALL), Leukemia, Juvenile Myelomonocytic Leukemia (JMML), Splenectomy, and Bone Marrow Aspiration.

Frequently Asked Questions about Dr. Martina Crysandt

How do I make an appointment with Dr. Martina Crysandt?

You can book an appointment with Dr. Martina Crysandt by calling their office at 206-288-6956. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Martina Crysandt a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Martina Crysandt is classified as an Distinguished expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Martina Crysandt specialize in?

While Dr. Martina Crysandt is a Hematology, they have specific expertise in Acute Myeloid Leukemia (AML), Leukemia, and Myelofibrosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Martina Crysandt participate in research or clinical trials?

Yes. Dr. Martina Crysandt has published 63 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. Martina Crysandt's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Crysandt's expertise for a condition
ConditionClose
    View All 7 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile